trial

Do Consumer Providers Enhance Recovery?

NCTId NCT00781079
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 285 (actual)
Sponsored by VA Office of Research and Development
Primary completion 2011-04
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
285 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
None
Start
2008-04
Primary completion
2011-04
Eligibility
ALL

Interventions & indications

Drugs
Consumer Provider

Sponsors

VA Office of Research and DevelopmentLead Sponsor

Investigators

2
Matthew J. Chinman, PhDPrincipal Investigator
Amy N. Cohen, PhDPrincipal Investigator

Sites

7 total
Loma Linda, United StatesLong Beach, United StatesSan Diego, United StatesWest Los Angeles, United StatesIndianapolis, United StatesLas Vegas, United StatesPittsburgh, United States

Facts & assertions

4 sourced
Enrollment
285
Phase
NA
Primary Completion Date
2011-04
Status
COMPLETED
relationships
The graph out of here
drug
Consumer Provider
drug
lead_sponsor
VA Office of Research and Development
company
indication
Mental Disorder
indication
Schizophrenia
indication
Mental Disorders
indication
investigator
Matthew J. Chinman, PhD
person
Amy N. Cohen, PhD
person